Wright Medical Group (WMGI) Tops Q2 EPS by 11c, Updates FY Guidance

Wright Medical Group (NASDAQ: WMGI) reported Q2 EPS of ($0.11), $0.11 better than the analyst estimate of ($0.22). Revenue for the quarter came in at $170 million versus the consensus estimate of $172.47 million.

GUIDANCE:

Wright Medical Group sees FY2016 EPS of ($0.54)-($0.47), versus the consensus of ($0.61).

• Following the previously announced transaction with Corin, the company now anticipates net sales from continuing operations for full-year 2016 of approximately $675 million to $685 million, an increase from the company’s previous guidance range of $668 million to $678 million.

For earnings history and earnings-related data on Wright Medical Group (WMGI) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Algorhythm Holdings (RIME) Tops Q2 EPS by 54c
• Outlook Therapeutics (OTLK) Misses Q3 EPS by 9c